These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3510143)

  • 41. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS; Elahi D; Minaker KL; Rowe JW
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assessment of hepatic insulin action in obese type 2 diabetic patients.
    Staehr P; Hother-Nielsen O; Levin K; Holst JJ; Beck-Nielsen H
    Diabetes; 2001 Jun; 50(6):1363-70. PubMed ID: 11375337
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of the "dawn phenomenon" using an artificial endocrine pancreas].
    Khristov V; Petkova M; Tsanev A
    Vutr Boles; 1988; 27(6):35-8. PubMed ID: 3247701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients.
    Kerner W; Navascués I; Torres AA; Pfeiffer EF
    Metabolism; 1984 May; 33(5):458-64. PubMed ID: 6371444
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Differences in the dawn phenomenon between insulin regimens.
    Yagasaki H; Kobayashi K; Saitou T; Nagamine K; Mitsui Y; Mochizuki M; Kobayashi K; Cho H; Ohyama K; Amemiya S; Nakazawa S
    Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):195-9. PubMed ID: 19834874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucose utilization in Type 1 (insulin-dependent) diabetes: Evidence for a defect not reversible by acute elevations of insulin.
    Proietto J; Nankervis A; Aitken P; Caruso G; Alford F
    Diabetologia; 1983 Oct; 25(4):331-5. PubMed ID: 6357915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human and porcine insulins are equally effective in the regulation of glucose kinetics of diabetic patients during exercise.
    Koivisto VA; Pelkonen R; Nikkilä EA; Heding LG
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):500-5. PubMed ID: 6393677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-insulin-dependent diabetic patients (NIDDMs) do not demonstrate the dawn phenomenon at presentation.
    Atiea JA; Vora JP; Owens DR; Luzio S; Read GF; Walker RF; Hayes TM
    Diabetes Res Clin Pract; 1988 May; 5(1):37-44. PubMed ID: 3042344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
    Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
    J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exercise-induced hypoglycaemia and subcutaneous insulin infusion.
    Edelmann E; Staudner V; Bachmann W; Walter H; Haas W; Mehnert H
    Diabet Med; 1986; 3(6):526-31. PubMed ID: 2951207
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Role of growth hormone in the pathogenesis of dawn phenomenon in IDDM].
    Mimura A; Kageyama S; Itoh K; Miura J; Kurata H; Yokoyama J; Ikeda Y
    Nihon Naibunpi Gakkai Zasshi; 1992 Jun; 68(6):600-6. PubMed ID: 1633930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus: magnitude, frequency, variability, and dependency on glucose counterregulation and insulin sensitivity.
    Perriello G; De Feo P; Torlone E; Fanelli C; Santeusanio F; Brunetti P; Bolli GB
    Diabetologia; 1991 Jan; 34(1):21-8. PubMed ID: 2055337
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin pump treatment: effect on glucose homeostasis, metabolites, hormones, insulin antibodies and quality of life.
    Beck-Nielsen H; Richelsen B; Schwartz Sørensen N; Hother Nielsen O
    Diabetes Res; 1985 Jan; 2(1):37-43. PubMed ID: 3888495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients.
    Guerci B; Meyer L; Sallé A; Charrié A; Dousset B; Ziegler O; Drouin P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2673-8. PubMed ID: 10443658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased hypoglycemic effect of insulin at night in insulin-dependent diabetes mellitus and healthy subjects.
    Garrel DR; Bajard L; Harfouche M; Tourniaire J
    J Clin Endocrinol Metab; 1992 Jul; 75(1):106-9. PubMed ID: 1618996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG; Kruszynska YT; Mulford MI; Olefsky JM
    Diabetes; 1999 Dec; 48(12):2414-21. PubMed ID: 10580431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The dawn phenomenon and diabetes control in treated NIDDM and IDDM patients.
    Atiea JA; Luzio S; Owens DR
    Diabetes Res Clin Pract; 1992 Jun; 16(3):183-90. PubMed ID: 1425138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
    Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
    J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production.
    Boden G; Chen X; Urbain JL
    Diabetes; 1996 Aug; 45(8):1044-50. PubMed ID: 8690150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.